Burkitt's tumor and immunotherapy. Coryne vaccination
Mazet, G.
Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 67(4): 353-359
1974
ISSN/ISBN: 0037-9085 PMID: 4377236 Document Number: 81379
Document emailed within 1 workday
Related Documents
Gravell, M.; Levine, P.H.; McIntyre, R.F.; Land, V.J.; Pagano, J.S. 1976: Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB) Journal of the National Cancer Institute 56(4): 701-704Hoshino, T.; Jiang, Y.Z.; Dunn, D.; Paul, D.; Qazilbash, M.; Cowan, K.; Wang, J.; Barrett, J.; Liu, J. 1998: Transfection of interleukin-12 cDNAs into tumor cells induces cytotoxic immune responses against native tumor: implications for tumor vaccination Cancer Gene Therapy 5(3): 150-157
Nechiporenko, V.P.; Makovskaia, V.I.; Bibliuk, I.I. 1970: Burkitt's tumor (case report) Voprosy Onkologii 16(12): 67-70
Gómez Campderá, F.J.; López Gómez, J.M.; Delgado, J.; Ramos, M.; Morales, J.L.; Lugue, A.; Gómez Campderá, J. 1985: Burkitt's lymphoma and tumor lysis syndrome Revista Clinica Espanola 176(4): 210-211
Eggermont, A.M.; Sugarbaker, P.H. 1990: Immunogenicity of the tumor determines the outcome of immunotherapy with interleukin-2, ABPP, and cyclophosphamide of micro- and macrometastatic intraperitoneal tumor Cancer Detection and Prevention 14(4): 483-490
Tanaka, T.; Saito, T. 1975: Immunotherapy of cancer: induction of tumor immunity with a mixture of tumor cell-BCG, and the effect of intratumor injection of BCG and of nonliving BCG preparation Gan 66(6): 631-640
Weiss, D.W. 1980: The transplantation experience, tumor immunology, and tumor immunotherapy Transplantation Proceedings 12(4): 666-675
Dopatka, H.D.; Majer, M.; Hennessen, W.; Mauler, R. 1977: Interference of preceding BCG vaccination with BCG immunotherapy in L2C-guinea pig leukemia Developments in Biological Standardization 38: 359-362
Möller, P.; Wittig, B.; Schadendorf, D. 1998: Intratumoral adoptive immunotherapy with tumor infiltrating lymphocytes (TIL) in a melanoma patient leading to regression of local tumor mass. A case report Anticancer Research 18(2b): 1237-1241
Peiper, M.; Goedegebuure, P.S.; Eberlein, T.J.; Zornig, C. 1997: Cytotoxic T-lymphocytes and the recognition of tumor antigens--an approach to "preventive tumor vaccination?" Zentralblatt für Chirurgie 122(3): 141-148
Matsubara, H.; Tagawa, M.; Gunji, Y.; Takenaga, K.; Sugaya, M.; Urashima, T.; Koide, Y.; Suzuki, T.; Asano, T.; Ochiai, T.; Isono, K.; Kageyama, H.; Nakamura, Y.; Sakiyama, S. 1996: Study of irradiation effects on cytokine secretion from retrovirally-transduced tumor cells: a model for tumor vaccination Anticancer Research 16(2): 645-650
Schirrmacher, V.; von Hoegen, P.; Heicappell, R. 1989: Virus modified tumor cell vaccines for active specific immunotherapy of micrometastases: expansion and activation of tumor-specific T cells Progress in Clinical and Biological Research 288: 391-399
Nesterenko, O.A.; Andreev, L.V.; Nogina, T.M.; Shkaruba, V.V. 1980: Fatty acid composition of certain coryne- and nocardioform bacteria Mikrobiolohichnyi Zhurnal 42(3): 288-293
Ristau, E.; Beier, D.; Wittmann, W.; Klima, F. 1987: Protection of sheep against infection with bovine leukemia virus by vaccination with tumor cells or tumor cell preparations from lymph nodes of leukemic cattle Archiv für Experimentelle Veterinarmedizin 41(2): 185-196
Jerome, K.R.; Bu, D.; Finn, O.J. 1992: Expression of tumor-associated epitopes on Epstein-Barr virus-immortalized B-cells and Burkitt's lymphomas transfected with epithelial mucin complementary DNA Cancer Research 52(21): 5985-5990
Kucera, A.; Pýcha, K.; Pajer, P.; Spísek, R.; Skába, R. 2009: Dendritic cell-based immunotherapy induces transient clinical response in advanced rat fibrosarcoma - comparison with preventive anti-tumour vaccination Folia Biologica 55(4): 119-125
Payne, C.M.; Smith, W.L.; Grogan, T.M.; Nagle, R.B.; Paplanus, S.H.; Palmer, T. 1989: Ultrastructural morphometry distinguishes Burkitt's-like lymphomas from neuroendocrine neoplasms: useful criteria applied to the evaluation of a poorly differentiated neuroendocrine neoplasm of the nasal cavity masquerading as Burkitt's-like lymphoma Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 2(1): 35-45
Young, B.G.; Swart, B.E. 1970: Evidence for the presence of anti-Burkitt tumor globulins in pooled human immune globulins Cancer Research 30(3): 763-767
Mastrangelo, M.J.; Berd, D.; Maguire, H.C. 1984: Current condition and prognosis of tumor immunotherapy: a second opinion Cancer Treatment Reports 68(1): 207-219
Sarna, S.; Bhola, R.K. 1989: Adoptive immunotherapy of tumor in mice in combination with cyclophosphamide Archivum Immunologiae et Therapiae Experimentalis 37(5-6): 533-538